CAS 2587177-94-2

N-(3-Chlorophenyl)-8-[[1-(4-methyl-2-nitrophenyl)-1H-1,2,3-triazol-4-yl]methoxy]-2-quinazolinamine

Description:

N-(3-Chlorophenyl)-8-[[1-(4-methyl-2-nitrophenyl)-1H-1,2,3-triazol-4-yl]methoxy]-2-quinazolinamine is a synthetic organic compound characterized by its complex structure, which includes a quinazolinamine core and a triazole moiety. The presence of a chlorophenyl group and a nitrophenyl substituent contributes to its potential biological activity, possibly influencing its pharmacological properties. This compound may exhibit properties such as antimicrobial, antifungal, or anticancer activities, although specific biological effects would depend on further empirical studies. Its molecular structure suggests it may engage in hydrogen bonding and π-π stacking interactions, which are relevant for its solubility and reactivity. The compound's CAS number, 2587177-94-2, allows for precise identification in chemical databases, facilitating research and development in medicinal chemistry. As with many synthetic compounds, safety and handling precautions should be observed, and its stability under various conditions should be assessed for practical applications.

Formula: C₂₄H₁₈ClN₇O₃

Synonyms:

• N-(3-Chlorophenyl)-8-[[1-(4-methyl-2-nitrophenyl)-1H-1,2,3-triazol-4-yl]methoxy]-2-quinazolinamine

DB18

CAS: 2587177-94-2

DB18 serves as a potent, selective inhibitor of CDC2-like kinases (CLKs), exhibiting IC50 values between 10-30 nM for CLK1, CLK2, and CLK4. Additionally, it possesses anti-tumor activity [1].

Formula: C₂₄H₁₈ClN₇O₃

Color and Shape: Solid

Molecular weight: 487.9

Ref: TM-T86165